SARI, Isti Kartika et al. Preclinical Evaluation of HPV Type 52 L1L2 Chimeric Protein as a Cervical Cancer Vaccine Candidate. HAYATI Journal of Biosciences, [S. l.], v. 33, n. 3, p. 556–565, 2025. DOI: 10.4308/hjb.33.3.556-565. Disponível em: https://journal.ipb.ac.id/hayati/article/view/68333. Acesso em: 2 jan. 2026.